Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT00490451
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of soft tissue sarcoma that is unresectable or metastatic
* Have received one or two (but no more than two) prior treatment regimens for metastatic soft tissue sarcoma, one of which must have included doxorubicin (adriamycin).
* Must have stopped all previous treatments for cancer, including chemotherapy, radiation therapy or other investigational treatments for cancer for at least 30 days
Exclusion Criteria:
* Participants with primary bone sarcoma (for example osteosarcoma, Ewing's sarcoma, chondrosarcoma), gastrointestinal stromal tumor (GIST) and Kaposi's sarcoma
* Serious pre-existing medical problems (as determined by your doctor)
* Have received more than two previous systemic treatment regimens for unresectable or metastatic soft tissue sarcoma
* Have a second primary cancer (unless cancer-free for more than 2 years)
* Active treatment with Warfarin (Coumadin)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00490451
Study Brief:
Protocol Section:
NCT00490451